May 25, 2022 - Duomed Group and The Surgical Company Group (‘TSC Group’) are pleased to announce the completion of the acquisition by Duomed Group of the distribution activities of TSC Group in France and the Benelux, notably the Adhesia, Sebac and Hospithera brands.
With this transaction, Duomed Group creates one of the leading European distributors of medical devices, consumables and related services with activities in the Benelux, France, the UK, Switzerland and Scandinavia. Driven by highly complementary activities and 600 dedicated employees, the combination will be able to enhance its product and service offering to customers as well as provide deeper market access to its international network of renowned suppliers. Over 2022, pro-forma consolidated sales of EUR 270m are expected to be realized.
Reinier van der List, Chief Executive Officer of Duomed Group, commented: “The healthcare community is dynamic and continues to evolve rapidly. The acquisition announced today, offers many opportunities for both parties to build a future-oriented and strong organisation. We look forward to a good and promising cooperation.”
Luc Van Schil, Chief Executive Officer of TSC Group, added: “We are very pleased to see our distribution business joining forces with the Duomed Group. The combined organisation that is created, will be able to take a frontrunning position in the European specialty medtech distribution space. This offers new and exciting opportunities to our customers, suppliers and employees.”
About Duomed Group
Duomed Group, headquartered in Benelux, is a fast-growing European leading distributor of medical supplies, operating in a continuously growing market. The group is one of the early adopters in consolidating the market potential, which still is very fragmented. Duomed is active in the clinical fields of amongst others endoscopy, surgery, acute care and diagnostics with consolidated sales in 2021 of EUR 130m. For more information, please visit www.duomedgroup.com.
About TSC Group
TSC Group, headquartered in the Netherlands, is a private group of specialty medtech production and distribution companies with over 400 employees and around EUR 160m in annual sales. Post transaction, TSC Group will further expand its global proprietary product business in the areas of patient temperature management, single-use endoscopy, wireless patient monitoring and non-invasive hemodynamic assessment. For more information, please visit www.tsc-group.com.